The American Association of Equine Practitioners, in an effort to educate members, has issued guidelines for the responsible use of compounded medications by veterinarians.
The American Association of Equine Practitioners has announced plans to host an Unwanted Horse Summit. The summit, a one-day conference bringing equine industry leaders together to address the problem of unwanted horses, will take place Tuesday, April 19, 2005, during the American Horse Council's annual meeting in Washington, D.C.
Dr. William O. Reed died Saturday morning at Winthrop Hospital in Mineola, N.Y. He was 83 years old.
By Dr. Tom R. Lenz -- Federal legislation to ban the slaughter of horses in the United States for human consumption has become an emotional issue on which some groups within the equine industry can't see eye to eye. Here are the facts regarding the American Association of Equine Practitioners' position on H.R. 857, the American Horse Slaughter Prevention Act.
Blue Horse Charities has stepped up the campaign for passage of legislation to ban horse slaughter with a strongly worded letter and a full-page advertisement on the back page of the Nov. 8 edition of Daily Racing Form.
Ray Paulick, editor in chief of The Blood-Horse and executive vice president and editorial director of Blood-Horse Publications, has been selected as the American Association of Equine Practitioners' (AAEP) equine industry representative on the group's board of directors.
Is there a horse doctor in the house? If the job trend for veterinary school graduates continues as it has for the past few years, then the answer might be "no."
As Funny Cide continues in his pursuit of the Triple Crown, it is bringing to the fore the question of why some horses are gelded and others are not. Dr. Larry Bramlage, on-call veterinarian for the American Association of Equine Practitioners, sheds light on the subject.
The American Association of Equine Practitioners (AAEP) issued a statement in early March about its stance regarding genetic defects and their treatment.
- By Ray Paulick
By Ray Paulick -- Major League Baseball is trying to come to grips with a growing drug scandal involving anabolic steroids that some people feel already has tarnished some of the sport's most sacred records. It's one scandal that, for now, racing has managed to avoid.
The board of directors of the Kentucky Thoroughbred Association has formally stated its "dissatisfaction" with current medication policies in the Bluegrass State.
As the Racing Medication and Testing Consortium continues its march toward uniformity in Thoroughbred racing, battle lines are being formed by other groups that believe a furosemide-only policy on race days is too extreme.
The American Association of Equine Practitioners created the On-Call program 11 years ago to assist media in understanding injuries and treatment of horses before, during, and after upper-echelon equine events. For this year's Kentucky Derby, the team is headed by Dr. Larry Bramlage.
The newly christened Racing Medication and Testing Consortium said May 1 it has formed three task forces to focus on developing an organizational and business plan, scientific research priorities, and a model medication policy.
A new Web site, www.EquineResearch.net, details current equine research funded by four major organizations.
As the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force prepared for its March 12 meeting, some racetrack veterinarians moved closer to forming their own organization.
The benefits of equine genome research will be explored during a presentation on March 2 at the American Quarter Horse Association (AQHA) convention in Dallas, Texas. "Genome Research 101 for the Horse Industry" will be held from 8:00 a.m.-3:30 p.m. (CST) at the Hotel Inter-Continental Dallas. It will sponsored by the the American Association of Equine Practitioners (AAEP), AQHA, Grayson-Jockey Club Research Foundation, and the Morris Animal Foundation.
Representatives from about 20 industry organizations unanimously endorsed a plan to develop a national medication policy during a teleconference Jan. 28. The action followed the first Racehorse Medication Summit, held Dec. 4, 2001, in Tucson, Ariz.
The attached list of racing organizations and officials were invited to attend a one-day workshop for the purpose of determining if agreement could be reached as to the need for a uniform policy for racehorse medication in the United States, and if so, where agreement can be reached on elements of such a policy. The workshop consisted of two segments: a two-hour open session briefing by experts on topics pertinent to the purpose of the Summit, and an intensive seven-hour workshop for the invited representatives which was conducted by a professional facilitator from outside the racing industry.
Three industry officials gave their views Thursday night on issues they expect will figure prominently in 2002. It came as no surprise the issues are medication, economics, and legislation.
The official report on the Dec. 4 Racehorse Medication Summit organized by the American Association of Equine Practitioners could be released Jan. 4. The document is expected to provide information on consensus reached by the more than 30 industry officials who participated.
California is on board with a nationwide push for a consensus on racehorse medication, the president of the Thoroughbred Owners of California reported to his board the week of Dec. 10. But the TOC does have its own opinions on some of the specifics.
The second round of "super-test" results from the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force should be released early in January, said Jim Gallagher, executive director of the task force.
Participants at Tuesday's Racehorse Medication Summit in Tucson, Ariz., reached a consensus on medication, drug-testing, security, and enforcement, but said much of any future policy depends on scientific determinations. The group of about 30 industry officials did agree on the need for a uniform medication policy and decision levels for therapeutic medications, but specifics weren't discussed.
Racing industry participants expressed hope Tuesday morning that a five-hour facilitated session on medication would at least serve as a starting point toward uniformity. No one expected radical changes in current policies that vary by jurisdiction in the United States.
The Thoroughbred Horsemen's Association on Nov. 27 issued a list of recommendations that call for a restructuring of medication use and drug testing procedures in horse racing. Among them are formation of a non-profit consortium that would be funded via a per-start fee for every Thoroughbred, Standardbred, and Quarter Horse.
The American Association of Equine Practitioners has spent many hours over the past year getting ready for the Dec. 4 medication summit that will be part of the University of Arizona Race Track Industry Program's Symposium on Racing. "We hope for the first time to bring together key stakeholders in the racing industry to specifically discuss racehorse medication," said Dr. Wayne McIlwraith, 2001 president of the AAEP.
The University of Arizona Race Track Industry Program hopes to make the results of its medication survey available at its Symposium on Racing, scheduled for the first full week of December. A major medication summit will be held Dec. 4 of that week in Tucson.
Officials with the American Association of Equine Practitioners acknowledge that their "Racehorse Medication Summit" planned for Dec. 4 appears to have moved some organizations to action. But they admit the complex issue of medication and drug-testing can't be addressed in one day.
A group of racetrack veterinarians have offered their own proposal for "universal race-day medication and testing," and have told the American Association of Equine Practitioners they want their collective voice heard during a medication summit planned for Dec. 4 in Tucson, Ariz.
More than 2,5000 practitioners are expected for the 47th American Association of Equine Practitioners annual convention Nov. 24-28 in San Diego, Calif.
The American Association of Equine Practitioners has formed a task force to identify therapeutic medications used in racehorses. The organization was approached by the Testing Integrity Program, commonly known as TIP.
When you bandage a horse's legs, it is important to use proper techniques. If bandages are not applied correctly, they can cause discomfort, restrict blood flow, and damage tendons and other tissues.
Race-day medication is a necessity, but there should be limits on the use of therapeutic drugs to treat horses that are competing, Eclipse Award-winning trainer Bob Baffert told the American Association of Equine Practitioners on Sunday. Baffert was the keynote speaker for the organization's annual convention in San Antonio, Texas.
A call for uniform medication guidelines and restrictions on therapeutic medications on race day has won praise and concern.
Most Popular Stories
- Palace Malice Interest Sold, May Race Again
- 'Chrome' Eyes BC Classic, Bayern Has Options
- Beholder Fires Bullet for Zenyatta Defense
- Guillot, Jerkens Like Chances in Gold Cup
- Shared Belief Works Toward Awesome Again
- Wise Dan Preps for Shadwell Turf Mile
- Believe You Can to Fasig-Tipton Sale
- Twirling Candy Colt Leads Tattersalls Sale
- Suffolk Downs Adds Race Day for Tribute
- Fasig-Tipton Catalogs 1,236 for October Sale